vaccine – The Inside Adviser

Best week in nine for the ASX, even after AstraZeneca setback

April 11, 2021 by The Inside Adviser

ASX delivers strong gains, gold shining again, travel hit by vaccine issues The ASX200 (ASX:XJO) finished the week flat but managed to deliver a strong 2.4% from just four days of trading....

Strongest month since November as ASX gains 1.8%

March 31, 2021 by The Inside Adviser

ASX positive, Zip Co (ASX:Z1P) teams up with JB HiFi, building approvals heat up The ASX200 (ASX:XJO) posted another positive day as the quarter comes to an end, finishing 0.8% higher. Whilst...

ASX200 0.4% higher, quiet day of news

January 25, 2021 by The Inside Adviser

ASX200 0.4% higher, quiet day of news, Fortescue (ASX:FMG), Zip Co (ASX:Z1P) among the strongest The ASX200 (ASX:XJO) finished 0.4% higher on very light volume with most participants clearly opting for a...

DNR Capital: “Quality companies poised to win”

July 28, 2020 by Contributor

Market risks appear more balanced, quality companies poised to win market share.